<DOC>
	<DOCNO>NCT02835911</DOCNO>
	<brief_summary>This registry study intend establish large prospective longitudinal clinical cohort lymphoma patient Malawi , data currently lack sub-Saharan Africa . The investigator perform core biopsy least 800 consecutively enrolled patient suspect lymphoma accurate histopathologic characterization . The investigator systematically collect relevant clinical laboratory data , longitudinally follow confirm hematologic malignancy receive treatment accord local standard care assess outcome .</brief_summary>
	<brief_title>Clinical Cohort Lymphoma Patients Malawi</brief_title>
	<detailed_description>This observational cohort registry study least 800 patient suspected lymphoma Malawi . The primary purpose study develop large prospective longitudinal lymphoma cohort Kamuzu Central Hospital ( KCH ) . Subjects confirm hematologic malignancy treat accord local standard care actively follow 2 year diagnosis assess clinical outcome . After 2 year , subject well , discharge clinic desire contact via telephone every 6 month 5 year lymphoma diagnosis simply assess vital status . Subjects wish continue clinic follow-up 2 year see every 6 month 5 year lymphoma diagnosis . Those unwell 2 year continue receive active treatment continue follow-up clinic treatment detail record . All study laboratory procedure perform consistent international standard care . Even without study implementation , procedure may undergo patient KCH , 'new ' intervention provide study currently absent Malawi . However , current clinical laboratory assessment lymphoma patient KCH time typically highly inconsistent incomplete international standard , result extreme scarcity resource personnel . It therefore hop study provide great standardization uniformity longitudinal characterization patient lymphoma KCH , allow data collect used clinical well research purpose , data sub-Saharan Africa lack tremendously informative .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Criteria : Referred Kamuzu Central Hospital ( KCH ) clinically suspect lymphoma base clinical impression refer provider Age &gt; 5 year , â‰¤5 year lymphoma already pathologically confirm . No prior concurrent histologically confirm cancer diagnosis receipt cancer treatment . Residence &lt; 200 kilometer KCH . Able understand comply study procedure entire length study , assistance parent guardian applicable . Subject ( parent guardian applicable ) able understand provide write consent English Chichewa . Informed consent review signed patient , pediatric patient , parent guardian . There exclusion criterion failure meet inclusion criterion list . Patients may consent participation study refuse direct genomic analysis lymphoma specimen .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>